Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


ODE Reorganization Reduces Reviewer-To-Manager Ratio

This article was originally published in The Gray Sheet

Executive Summary

A restructuring in the Office of Device Evaluation, incorporating dozens of new hires, is intended to reduce the number of reviewers reporting to each manager. It took effect last week.


Related Content

FDA Office Of Device Evaluation: People, Products On The Move
CDRH’s Division of Cardiovascular Devices Starts 30-Day Notice Reviews
Multiple MDUFA Policies In Transition Phase Until Jan. 1
OIVD Becomes OIR: FDA Diagnostic Office Adds Entire Radiological Health Program
FDA Manufacturing-Change Reviews Will Shift From Compliance Office To ODE
Regulatory News In Brief
Device Industry Expects Quicker Path To Market In Exchange For Doubling Of User Fees





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts